Rhumbline Advisers INNOVATE BIOPHARMACEUTICALS IN Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
N/A
-22,972 Closed
0 $0
Q1 2019

May 01, 2019
SELL
N/A
-400 Reduced 1.71%
22,972 $44,000
Q4 2018

Jan 31, 2019
BUY
N/A
7,490 Added 47.16%
23,372 $54,000
Q3 2018

Nov 07, 2018
SELL
N/A
-987 Reduced 5.85%
15,882 $108,000
Q2 2018

Aug 06, 2018
BUY
N/A
16,869 New
16,869 $398,000
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email